<DOC>
	<DOCNO>NCT01369745</DOCNO>
	<brief_summary>Thus study test experimental drug call Z-102 ( combination prednisolone dipyridamole ) treat patient moderate severe rheumatoid arthritis .</brief_summary>
	<brief_title>A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis</brief_title>
	<detailed_description>The primary objective study demonstrate efficacy Z102 ( 2.7 mg prednisolone/360 mg dipyridamole ) versus placebo Disease Activity Score 28 use C reactive protein ( DAS28-CRP ) subject rheumatoid arthritis study endpoint 12 week</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<criteria>Meet ACR / EULAR criterion classification RA Have moderate severe RA , define involve minimum ( ≥6 total swollen ≥6 total tender ) 28 joint assess Have screen CRP level least 0.6 mg/dl DAS28CRP score ≥4.5 Have stable dose conventional DMARD therapy least 90 day without dosage adjustment modification able maintain dose conventional DMARD therapy study participation ( without glucocorticoid therapy Treatmentrefractory patient exclude Has active cardiovascular disease , unless well control appropriate treatment minimum 3 month prior screen Is take aspirin reason cardiovascular prophylaxis total daily dose great 325 mg Is currently take steroid daily prednisone dose , equivalent , &gt; 10 mg Intraarticular , intramuscular , intravenous glucocorticoid must give least 6 week prior enter study The need continue use one multiple NSAID 's time , use acetaminophen chronic basis All opiate use prohibit Use medication herbs use treatment pain prohibit Patients history currently active tuberculosis per specific country guideline exclude Has uncontrolled diabetes mellitus define serum glucose &gt; 126 mg/dl Knowingly HIV infection hepatitis Has undergone administration investigational drug within 30 day study initiation All biologic agent exclude 90 day prior Screening throughout study . Has undergone administration rituximab Bcell deplete investigational drug within 6 month study initiation Has history alcohol drug abuse within past 2 year Has history hypersensitivity glucocorticoid and/or dipyridamole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Moderate severe</keyword>
</DOC>